Back to Country Index COUNTRY PROFILE
Nuclear Biological Chemical Missile
Access Newswire
Country Information
 
Biological Facilities

Central Research Institute
 
Source: CRI website
Other Names: CRI
Address: Kasauli 173204
Website:
http://www.crikasauli.com
Phone: Unknown
Email: director@crikasauli.com
Subordinate to: Government of India
Size: Unknown
Primary Function: The institute performs research and development in the fields of immunology and "vaccinology."

History:
Established on 3 May 1905 by Dr. David Sample to develop vaccines. In 1911, Dr. Sample first developed a rabies tissue vaccine from the brains of sheep deliberately infected and then killed.

Activities:
The institute performs large-scale production of bacterial and viral vaccines and serum. It has developed DPT, DT, tetanus, cholera, and typhoid vaccines, and is the only producer in India of rabies vaccine. It also produces snake antivenin.

The institute is currently working on the standardization of a modified single radial immunodiffusion test for rapid determination of rabies vaccine potency. The institute is also conducting stability studies of rabies vaccine exposed to different temperatures over various time periods. Furthermore, it is conducting studies on the effects of pertussis toxin, using the mouse weight gain test in order to establish the toxicity of pertussis vaccine. The institute is performing a standardization of in-vitro technique for passive hemagglutination inhibition for the estimation of potency of the cobra venom antiserum, and is also working on a vaccine for the Japanese encephalitis virus (JEV) using the brain tissue from a mouse's brain.

It has been reported that over the past four decades, the institute has annually produced about 100 tons of hazardous biomedical waste without the use of any pollution control devices.

The institute is a WHO Collaborative Center for the surveillance of influenza. The institute is an active member of the Influenza Surveillance Program under WHO guidelines. It also has a Polio Vaccine Testing Laboratory, which conducts tests of polio vaccines imported from other countries.

The National Salmonella and E. Coli Center is situated within the institute and is involved in identifying and typing Salmonella spp. and E. coli from within India and around the world. The center is run by the WHO in collaboration with the Central Public Health Laboratory located in London. The center has previously attempted to work on an anti-salmonella drug, research which resulted in the discovery of chloramphenicol resistance in S. typhi.

The Quality Control Division of the institute is responsible for testing all products produced by the institute. It works with the Central Drugs Laboratory in the testing of vaccines and serum, which fall under the Drugs and Cosmetic Act of 1940. All drug companies in India must have their vaccine or serum tested and approved by this division before they can market it.

The Biochemistry Division undertakes quality control tests on immunological agents and human blood products.

The Bacterial Vaccines Division comprises four units, the Finals Sterility Unit, the Central Sterilization and Media Unit, the Central Containerization Unit, and the Mycoplasma Unit. The division is tasked with developing the anti-cholera and anti-typhoid vaccine, and has attempted to produce the anti-cholera vaccine in a fermenter using liquid medium.

The institute provides instruction and training in the field of microbiology and the production and quality control of vaccines and serum. In addition, it gives expert advice for the treatment and management of dog and snake bites.

Key Sources: Central Research Institute, Kasauli, <http://mohfw.nic.in/kk/95/ib/95ib0q01.htm>; "Careers in Labs, Research Institutes and Allied Fields," <http://www.webindia123.com/career/other/reslab.html>; Kasauli, Himachal Pradesh, India, <http://travel.indiainfo.com/packages/hillstations/kasauli.html>; Sachin Chaturvedi and Beena Pandey, "Vaccine Policy in India," Biotechnology and Development Monitor, December 1995, <http://www.biotech-monitor.nl/2503.htm>; C.R. Sukumar, "High Court Directs AP to Alter Vaccine Tenders," Business Line, 12 November 2002, <http://www.thehindubusinessline.com/2002/11/12/stories/
2002111202560400.htm>; Keya Achary, "Man's Best Friend?" Humanscapeindia.net, October 2001, <http://www.humanscapeindia.net/humanscape/new/oct01/mansbest.htm>; Central Research Institute, <http://www.crikasauli.com>; "Report by the Finance and Appropriation Accounts of the Government of Himachal Pradesh for the year 2000-2001," p. 10.



 

Updated September 2003



Overview
All India Institute of Medical Sciences
BCG Laboratory, Madras
Bioinformatics Center, University of Pune
Bio-Instruments
Biological Evans Limited
Center for Advanced Studies in Veterinary Parasitology
Center for Biochemical Technology
Center for Biotechnology, Jawahar Lal Nehru University
Central Research Institute
Defense Bioengineering and Electro-Medical Lab
Defense Food Research Laboratory
Defense Institute of Physiology & Allied Sciences
Defense Material and Stores R&D Establishment
Hitech Bio-Services
Indian Council of Medical Research
Indian Institute of Chemical Biology


India Maps
Background on Relations Between India and Pakistan
Nuclear Proliferation and South Asia: Recent Trends
Implications of Proposed India-U.S. Civil Nuclear Cooperation
Seven Years After the Nuclear Tests: Appraising South Asia's Nuclear Realities
Background on Relations between India and Pakistan
Comprehensive Test Ban Treaty (CBTB)
Indo-Pakistani Military Standoff: Why It Isn’t Over Yet
Treaties and Organizations
Bhaba Atomic Research Centre (BARC)
Center for Nonproliferation Studies (CNS): South Asia
FAS: India Special Weapons Guide
India-Pakistan, Joint Declaration on the Complete Prohibition of Chemical Weapons
U.S. Nuclear Cooperation with India: Issues for Congress
Carnegie: India Resources
The U.S.-India Nuclear Deal



Search for:


Enter query terms separated by spaces.
Match:
Search in: Select any one of the following databases and archives or search any combination.
Click here for more details.
Entire Web Site
Global Security Newswire
Country Profiles
WMD 411
Issue Briefs & Analysis
Securing the Bomb
NTI Press Room
Source Documents
HEU Reduction and Elimination Database
Submarine Proliferation Database
Russian Language Resources
NIS Nuclear and Missile Database
NIS Nuclear Trafficking Database

Country Information
Argentina
Belarus
Brazil
China
Cuba
Egypt
France
India
Iran
Iraq
Israel
Japan
Kazakhstan
Libya
North Korea
Pakistan
Russia
South Africa
South Korea
Syria
United Kingdom
United States
Ukraine
Uzbekistan
Yugoslavia
Other


Research Library
Country Information Glossary
Issues & Analysis Source Documents
Databases Warheads & Materials
 

back to top

About This Section   

CNSThis material is produced independently for NTI by the James Martin Center for Nonproliferation Studies at the Monterey Institute of International Studies and does not necessarily reflect the opinions of and has not been independently verified by NTI or its directors, officers, employees, agents. Copyright © 2007 by MIIS.

HOME   | CONTACT US   | GET INVOLVED   | SITE MAP